Effects of Dexmedetomidine on Patients With Coronary Heart Disease After Percutaneous Coronary Intervention
Status:
Unknown status
Trial end date:
2017-12-31
Target enrollment:
Participant gender:
Summary
Coronary heart disease has a high incidence and high death rate. Percutaneous coronary
intervention (PCI) is an important method for the treatment of coronary heart disease (CHD).
However, PCI may cause myocardial cell injury and myocardial infarction 4 Type(MI4a, Type 4 a
myocardial infarction related to PCI). Dexmedetomidine(Dex) is the only anesthetic which has
sedative and analgesic effects. Dex currently has been widely used in perioperative
management of various surgical.This study intends to verify the effect of heart protection of
Dex in perioperative.
Phase:
Early Phase 1
Details
Lead Sponsor:
First Affiliated Hospital Xi'an Jiaotong University